Drug profile · INN
irinotecan hydrochloride trihydrate
ONIVYDE PEGYLATED LIPOSOMAL (PREVIOUSLY ONIVYDE)
irinotecan hydrochloride trihydrate (ONIVYDE PEGYLATED LIPOSOMAL (PREVIOUSLY ONIVYDE)) is a dna topoisomerase i inhibitor.
EMA: approved Antineoplastic and immunomodulating agents (L01) L01CE02
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — irinotecan hydrochloride trihydrate
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
irinotecan hydrochloride trihydrate (ONIVYDE PEGYLATED LIPOSOMAL (PREVIOUSLY ONIVYDE)) is a dna topoisomerase i inhibitor.
Key facts
INN irinotecan hydrochloride trihydrate
Brand ONIVYDE PEGYLATED LIPOSOMAL (PREVIOUSLY ONIVYDE)
Mechanism DNA topoisomerase I inhibitor
Target DNA topoisomerase 1
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01CE02
Mechanism of action
DNA topoisomerase I inhibitor
Primary target: DNA topoisomerase 1
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is irinotecan hydrochloride trihydrate?
irinotecan hydrochloride trihydrate (ONIVYDE PEGYLATED LIPOSOMAL (PREVIOUSLY ONIVYDE)) is a dna topoisomerase i inhibitor.
What is the brand name for irinotecan hydrochloride trihydrate?
ONIVYDE PEGYLATED LIPOSOMAL (PREVIOUSLY ONIVYDE) is a marketed brand name for irinotecan hydrochloride trihydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.